Share
Market Research Report

BACTERIAL VACCINES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Vaccine TypePertussis (Whooping Cough) Vaccines · Tetanus Vaccines · Diphtheria Vaccines · Pneumococcal Vaccines · Meningococcal Vaccines · Typhoid Vaccines · Tuberculosis (TB) Vaccines · Cholera Vaccines · Shigellosis Vaccines · and Others
  • By Patient Age GroupPediatric Vaccines (Infants, Children) · Adolescent Vaccines · Adult Vaccines · and Geriatric Vaccines
  • By Route of AdministrationIntramuscular · Intravenous · Subcutaneous · and Others
  • By Distribution ChannelPublic and Private
  • By GeographyNorth America · Latin America · Europe · Asia Pacific · Middle East & Africa
  • Published In29 Apr 2026
  • Report CodeCMI5877
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Vaccine Type
      • Market Snippet, By Patient Age Group
      • Market Snippet, By Route of Administration
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Driver
      • Restraints
      • Opportunities
    • Key Highlights
    • Regulatory Scenario
    • Recent Trends
    • Product Launches/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Mergers, Acquisitions, and Collaborations
  4. Global Bacterial Vaccines Market, By Vaccine Type, 2021 - 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Pertussis (Whooping Cough) Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
    • Tetanus Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
    • Diphtheria Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
    • Pneumococcal Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
    • Meningococcal Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
    • Typhoid Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
    • Tuberculosis (TB) Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
    • Cholera Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
    • Shigellosis Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  5. Global Bacterial Vaccines Market, By Patient Age Group, 2021 - 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Pediatric Vaccines (Infants, Children)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
    • Adolescent Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
    • Adult Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
    • Geriatric Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  6. Global Bacterial Vaccines Market, By Route of Administration, 2021 - 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Intramuscular
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
    • Intravenous
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
    • Subcutaneous
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  7. Global Bacterial Vaccines Market, By Distribution Channel, 2021 - 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Public
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
    • Private
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  8. Global Bacterial Vaccines Market, By Region, 2021 - 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, By Region, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, For Region, 2022 –2033
      • Country Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Patient Age Group, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Patient Age Group, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Patient Age Group, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Patient Age Group, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Patient Age Group, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Patient Age Group, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(US$ Bn)
        • South Africa
        • North Africa
        • Central Africa
  9. Competitive Landscape

    • Company Profie
      • GSK plc
        • Company Highlights
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Pfizer Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Merck & Co., Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Sanofi
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Johnson & Johnson Service, Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Serum Institute of India Pvt. Ltd.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Bharat Biotech
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Biological E. Limited
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Astellas Pharma Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Seqirus (CSL Limited)
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • AstraZeneca
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Novavax, Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Bavarian Nordic A/S
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Emergent BioSolutions Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Valneva SE
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Takeda Pharmaceutical Company Limited
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Boehringer Ingelheim International GmbH
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Immunomic Therapeutics, Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Moderna, Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Clover Biopharmaceuticals
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Analysts’ Views
  10. Section

    • References
    • Research Methodology
    • About us

*Browse 43 market data tables and 41 figures on "Global Bacterial Vaccines Market” - Global forecast to 2033